JP2011057693A5 - - Google Patents

Download PDF

Info

Publication number
JP2011057693A5
JP2011057693A5 JP2010256651A JP2010256651A JP2011057693A5 JP 2011057693 A5 JP2011057693 A5 JP 2011057693A5 JP 2010256651 A JP2010256651 A JP 2010256651A JP 2010256651 A JP2010256651 A JP 2010256651A JP 2011057693 A5 JP2011057693 A5 JP 2011057693A5
Authority
JP
Japan
Prior art keywords
alkynyl
alkenyl
alkyl
alkylsulfinyl
alkylsulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010256651A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011057693A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011057693A publication Critical patent/JP2011057693A/ja
Publication of JP2011057693A5 publication Critical patent/JP2011057693A5/ja
Pending legal-status Critical Current

Links

JP2010256651A 2001-07-13 2010-11-17 標的治療活性を有するテトラサイクリン化合物 Pending JP2011057693A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30554601P 2001-07-13 2001-07-13
US39574102P 2002-07-12 2002-07-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003511780A Division JP2004537544A (ja) 2001-07-13 2002-07-15 標的治療活性を有するテトラサイクリン化合物

Publications (2)

Publication Number Publication Date
JP2011057693A JP2011057693A (ja) 2011-03-24
JP2011057693A5 true JP2011057693A5 (US20070167479A1-20070719-C00034.png) 2013-01-24

Family

ID=29553007

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2003511780A Pending JP2004537544A (ja) 2001-07-13 2002-07-15 標的治療活性を有するテトラサイクリン化合物
JP2009187938A Expired - Fee Related JP5182956B2 (ja) 2001-07-13 2009-08-14 標的治療活性を有するテトラサイクリン化合物
JP2010256651A Pending JP2011057693A (ja) 2001-07-13 2010-11-17 標的治療活性を有するテトラサイクリン化合物
JP2010256652A Pending JP2011057694A (ja) 2001-07-13 2010-11-17 標的治療活性を有するテトラサイクリン化合物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2003511780A Pending JP2004537544A (ja) 2001-07-13 2002-07-15 標的治療活性を有するテトラサイクリン化合物
JP2009187938A Expired - Fee Related JP5182956B2 (ja) 2001-07-13 2009-08-14 標的治療活性を有するテトラサイクリン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010256652A Pending JP2011057694A (ja) 2001-07-13 2010-11-17 標的治療活性を有するテトラサイクリン化合物

Country Status (5)

Country Link
US (1) US20040063674A1 (US20070167479A1-20070719-C00034.png)
EP (11) EP2332548A1 (US20070167479A1-20070719-C00034.png)
JP (4) JP2004537544A (US20070167479A1-20070719-C00034.png)
AU (1) AU2002318238A1 (US20070167479A1-20070719-C00034.png)
WO (1) WO2003005971A2 (US20070167479A1-20070719-C00034.png)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
ES2260051T3 (es) * 1999-09-14 2006-11-01 Trustees Of Tufts College Metodo para preparar tetraciclinas substituidas con quimicas basadas en metales de transicion.
AU3105801A (en) 2000-01-24 2001-07-31 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
HUP0300082A2 (en) * 2000-03-31 2003-05-28 Paratek Pharmaceuticals 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline derivatives, process for their preparation and use and pharmaceutical compositions containing them
AU2001259701A1 (en) * 2000-05-15 2001-11-26 Paratek Pharmaceuticals, Inc 7-substituted fused ring tetracycline compounds
WO2001098236A2 (en) * 2000-06-16 2001-12-27 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
ATE544745T1 (de) 2000-07-07 2012-02-15 Tufts College 9-substituierte minocyclinverbindungen
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
WO2002072506A2 (en) * 2001-03-13 2002-09-19 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
MXPA03008165A (es) * 2001-03-13 2003-12-12 Paratek Pharm Innc Compuestos tetraciclina sustituidos en la posicion 7,9.
JP2005504722A (ja) 2001-03-14 2005-02-17 パラテック ファーマシューティカルズ インコーポレイテッド 相乗的抗真菌薬剤としての置換テトラサイクリン化合物
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
EP1404324B2 (en) * 2001-06-11 2011-04-06 XenoPort, Inc. Prodrugs of gaba analogs, compositions and uses thereof
EP2332548A1 (en) * 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of stroke
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
WO2003055441A2 (en) 2001-08-02 2003-07-10 Paratek Pharmaceuticals, Inc. Medicaments
EP1894569A3 (en) * 2001-10-05 2008-05-07 Tetragenex Pharmaceuticals, Inc. Tetracycline derivatives for treating cancer
AU2003235759A1 (en) * 2002-01-08 2003-07-24 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EA201000491A1 (ru) * 2002-03-08 2010-08-30 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
WO2003079984A2 (en) * 2002-03-21 2003-10-02 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
AU2003245295B2 (en) * 2002-05-20 2008-01-03 Collagenex Pharmaceuticals, Inc. Methods of treating allergic reactions
AU2003256496A1 (en) * 2002-07-12 2004-02-02 The Research Foundation Of State University Of New York Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
KR101148415B1 (ko) * 2002-07-12 2012-05-21 파라테크 파마슈티컬스, 인크. 3, 10, 및 12a 치환된 테트라시클린 화합물
WO2004014434A1 (en) * 2002-08-09 2004-02-19 Durkin Helen G A method for monitoring the effectiveness of tetracycline in the treatment of asthma
AU2003287217B2 (en) 2002-10-24 2010-03-04 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate RNA
AU2003287218C1 (en) * 2002-10-24 2010-07-15 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
DK2204168T3 (en) * 2003-04-07 2015-04-07 Supernus Pharmaceuticals Inc Tetracycline for administration once a day
EP2298323A3 (en) 2003-07-09 2011-05-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
EP2292590A3 (en) * 2003-07-09 2012-05-02 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
CN103040773A (zh) * 2003-07-25 2013-04-17 沃纳奇尔科特有限责任公司 多西环素金属络合物固体剂型
US20050148553A1 (en) * 2003-09-05 2005-07-07 Testa Raymond T. Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
UA83266C2 (en) * 2003-12-08 2008-06-25 Уайет Oxazole derivatives of tetracyclines
EP2332904A3 (en) 2004-01-15 2012-04-11 Paratek Pharmaceuticals, Inc. Derivatives of tetracycline compounds
AU2005244988C1 (en) 2004-05-21 2012-06-28 President And Fellows Of Harvard College Synthesis of tetracyclines and analogues thereof
WO2006009840A1 (en) * 2004-06-21 2006-01-26 Hutchison Medipharma Enterprises Limited Benzoquinone compounds as a anti-cancer agents
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
CA2585248A1 (en) 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP1805134B1 (en) * 2004-10-25 2012-06-20 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
BRPI0517227B8 (pt) 2004-11-04 2021-05-25 Xenoport Inc comprimido oral de liberação prolongada do ácido 1-{[alfa-isobutanoiloxietoxi)carbonil]amino metil}-1-cicloexano acético, e, uso do comprimido
US8088755B2 (en) * 2005-02-04 2012-01-03 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
JP2008530123A (ja) * 2005-02-09 2008-08-07 ジェネンテック・インコーポレーテッド マトリックスメタロプロテアーゼアンタゴニストを用いたher2のシェディングの阻害
US7879828B2 (en) 2005-03-14 2011-02-01 Wyeth Llc Tigecycline compositions and methods of preparation
US8211874B2 (en) * 2005-06-03 2012-07-03 Galderma Laboratories Inc. Inhibition of thrombin generation
US20070093455A1 (en) * 2005-07-21 2007-04-26 Paul Abato 10-substituted tetracyclines and methods of use thereof
RU2008121238A (ru) * 2005-12-22 2010-01-27 Вайет (Us) Способы лечения инфекций желудочно-кишечного тракта с применением тайгециклина
AU2006331688A1 (en) * 2005-12-22 2007-07-05 Wyeth Oral formulations comprising tigecycline
US20080027031A1 (en) * 2006-03-08 2008-01-31 Kinemed, Inc. Retinoids and Related Compounds for the Treatment of Neuroinflammatory Conditions, Diseases and Disorders
AU2007235279B2 (en) 2006-04-07 2012-12-06 President And Fellows Of Harvard College Synthesis of tetracyclines and analogues thereof
US20070286906A1 (en) * 2006-04-28 2007-12-13 Hutchison Medipharma Enterprises Limited Dihydrobenzoquinone compounds
EP3056487B1 (en) 2006-10-11 2018-02-21 President and Fellows of Harvard College Synthesis of enone intermediate
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
WO2008047340A1 (en) * 2006-10-19 2008-04-24 Mor Research Applications Ltd. Combined therapies of antipsychotic drugs and tetracyclines in the treatment of psychiatric disorders
CA2673466C (en) * 2006-12-21 2016-06-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
CA2892739A1 (en) * 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
CA2679448A1 (en) * 2007-02-28 2008-09-04 Aciex, Inc. Methods and compositions for normalizing meibomian gland secretions
CA2688725A1 (en) 2007-04-12 2008-10-23 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
US8518912B2 (en) 2007-11-29 2013-08-27 Actelion Pharmaceuticals Ltd. Phosphonic acid derivates and their use as P2Y12 receptor antagonists
CN102015602A (zh) * 2008-03-05 2011-04-13 帕拉特克药品公司 米诺环素化合物及其使用方法
PT2271348T (pt) * 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
EP2307027A4 (en) 2008-07-11 2012-08-15 Neumedics TETRACYCLINE DERIVATIVES WITH REDUCED ANTIBIOTIC ACTIVITY AND NEUROPROTECTIVE PROPERTIES
SG10201806714PA (en) 2008-08-08 2018-09-27 Tetraphase Pharmaceuticals Inc C7-fluoro substituted tetracycline compounds
CN102215681A (zh) * 2008-09-19 2011-10-12 帕拉特克药品公司 用于治疗类风湿性关节炎的四环素化合物和相关的治疗方法
US9073829B2 (en) 2009-04-30 2015-07-07 President And Fellows Of Harvard College Synthesis of tetracyclines and intermediates thereto
US9315451B2 (en) 2009-05-08 2016-04-19 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
NO2470500T3 (US20070167479A1-20070719-C00034.png) 2009-08-28 2018-03-03
US9327015B2 (en) * 2009-10-23 2016-05-03 DePuy Synthes Products, Inc. Methods and devices for correcting spinal deformity with pharmaceutical-eluting pedicle screws
CN101967108B (zh) * 2010-09-13 2013-06-19 苏春华 一种美他环素的衍生物
WO2012068670A1 (en) * 2010-11-23 2012-05-31 The University Of British Columbia Binding drugs with nanocrystalline cellulose (ncc)
JP6522498B2 (ja) * 2012-05-30 2019-05-29 パラテック ファーマシューティカルズ インコーポレイテッド 7−二置換フェニルテトラサイクリン誘導体
JP6301335B2 (ja) 2012-08-31 2018-03-28 テトラフェース ファーマシューティカルズ,インコーポレイテッド テトラサイクリン化合物
KR101660815B1 (ko) * 2013-06-13 2016-09-29 한국생명공학연구원 테트라싸이클린 유도체, 이의 약학적으로 허용가능한 염 또는 이의 입체이성질체를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물
WO2014200213A1 (ko) * 2013-06-13 2014-12-18 한국생명공학연구원 테트라싸이클린 유도체, 이의 약학적으로 허용가능한 염 또는 이의 입체이성질체를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물
KR101750834B1 (ko) 2014-10-07 2017-06-26 연세대학교 산학협력단 알파-시누클레인 응집체의 파괴에 의하여 파킨슨 질환을 치료 또는 예방하기 위한 조성물
MY197627A (en) * 2016-03-24 2023-06-29 Paratek Pharm Innc Methods for treating and preventing c. difficile infection
AU2017289278A1 (en) 2016-06-27 2019-01-17 Ohio State Innovation Foundation Liponucleotide-based therapy for ARDS
EP3529236B1 (en) 2016-10-19 2024-02-07 Tetraphase Pharmaceuticals, Inc. Crystalline forms of eravacycline
RU2019113715A (ru) 2016-11-01 2020-12-03 Паратек Фармасьютикалс, Инк. 9-аминометилминоциклиновые соединения и их применение для лечениия внебольничной бактериальной пневмонии(вбп)
CA3103614C (en) 2018-06-13 2024-05-28 Texas Tech University System Modified tetracycline for treatment of alcohol use disorder, pain and other disorders involving potential inflammatory processes
WO2020206321A1 (en) * 2019-04-04 2020-10-08 Cmtx Biotech Inc. Methods of treating charcot-marie-tooth disease
WO2020263484A1 (en) * 2019-06-28 2020-12-30 Mayo Foundation For Medical Education And Research Methods and materials for treating neuromyelitis optica spectrum diseases
WO2021207441A1 (en) 2020-04-10 2021-10-14 The Procter & Gamble Company Cleaning article with preferential rheological solid composition
US20220117458A1 (en) 2020-10-16 2022-04-21 The Procter & Gamble Company Cleaning article with preferential coating
WO2024075662A1 (ja) * 2022-10-03 2024-04-11 国立研究開発法人国立循環器病研究センター 脳卒中の検査方法、及び脳卒中の改善剤

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862225A (en) 1961-08-18 1975-01-21 Pfizer D-ring substituted tetracyclines
US3326761A (en) * 1964-11-16 1967-06-20 Pfizer & Co C 6-demethyl-6-deoxytetracycline, anti-tumor antibiotic
US3304227A (en) 1965-07-15 1967-02-14 Loyal E Loveless Antibiotic-containing animal feed
US4066694A (en) 1971-02-09 1978-01-03 Pfizer Inc. 4-hydroxy-4-dedimethylamino-tetracyclines
US3622627A (en) 1967-09-13 1971-11-23 Pfizer 4-dedimethylaminatetracycline and 5a, 6-anhydro derivatives thereof
US4806529A (en) 1982-11-18 1989-02-21 Trustees Of Tufts College, Tufts University Tetracycline activity enhancement
US4704383A (en) 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4925833A (en) 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
US4935412A (en) 1983-12-29 1990-06-19 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4666897A (en) 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
USRE34656E (en) 1983-12-29 1994-07-05 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency
US5308839A (en) 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
JP3016587B2 (ja) 1989-12-04 2000-03-06 ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク 非ステロイド抗炎症剤及びテトラサイクリンの配合
FR2660193B1 (fr) 1990-04-03 1994-11-04 Philippe Maincent Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules.
US5770588A (en) 1991-02-11 1998-06-23 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions of the prevention and treatment of root caries
EP0528810B1 (en) 1991-03-22 1996-02-07 CARSON, William S. Container and pickup assembly for collection of recyclable materials
US5231017A (en) 1991-05-17 1993-07-27 Solvay Enzymes, Inc. Process for producing ethanol
US5281628A (en) 1991-10-04 1994-01-25 American Cyanamid Company 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
DE69232302D1 (de) 1991-10-04 2002-01-31 American Cyanamid Co 7-Substituierte-9-substituierte Amino-6-Demethyl-6-Deoxy-Tetracycline
US5258371A (en) 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
US6043225A (en) 1992-06-12 2000-03-28 Board Of Regents Of The University Of Washington Diagnosis and treatment of arterial chlamydial granuloma
SG47520A1 (en) 1992-08-13 1998-04-17 American Cyanamid Co New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
US5284963A (en) 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
US5442059A (en) 1992-08-13 1995-08-15 American Cyanamid Company 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines
US5328902A (en) 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5420272A (en) 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
DE4227616C2 (de) 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
US5362754A (en) * 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
DE69304292T2 (de) 1992-11-17 1997-01-02 Univ New York Tetracycline inclusive nicht antimicrobiel wirksame, chemisch modifizierte Tetracycline hemmende exzessive Kollagenquervernetzung bei Diabetes
US5523297A (en) 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US6043231A (en) 1993-03-02 2000-03-28 The Research Foundation Of State Univ. Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5371076A (en) 1993-04-02 1994-12-06 American Cyanamid Company 9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
US5668122A (en) 1993-07-28 1997-09-16 Fife; Rose S. Method to treat cancer with tetracyclines
US5834450A (en) 1994-02-17 1998-11-10 Pfizer Inc. 9- (substituted amino) -alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
US5698533A (en) 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US5530557A (en) 1994-09-12 1996-06-25 International Business Machines Corporation Online placement of video files determined by a function of the bandwidth to space ratio of each of the storage devices in a server environment
US5843925A (en) 1994-12-13 1998-12-01 American Cyanamid Company Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
US5574026A (en) 1994-12-13 1996-11-12 American Cyanamid Company Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth
EP0736302A3 (en) * 1995-03-23 1997-06-04 Stichting Rega V Z W Protease inhibitors, DNA construction for protease expression and a method for measuring proteases and / or protease inhibitors
EP0733369A1 (en) * 1995-03-23 1996-09-25 Stichting REGA V.Z.W. Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors
JPH11504916A (ja) 1995-05-03 1999-05-11 ファイザー・インコーポレーテッド 新規テトラサイクリン誘導体
US5834449A (en) 1996-06-13 1998-11-10 The Research Foundation Of State University Of New York Treatment of aortic and vascular aneurysms with tetracycline compounds
US5827840A (en) 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5837696A (en) 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth
US5773430A (en) 1997-03-13 1998-06-30 Research Foundation Of State University Of New York Serine proteinase inhibitory activity by hydrophobic tetracycline
US5929055A (en) 1997-06-23 1999-07-27 The Research Foundation Of State University Of New York Therapeutic method for management of diabetes mellitus
US6165484A (en) * 1997-08-26 2000-12-26 Wake Forest University EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
JP4733266B2 (ja) 1997-12-19 2011-07-27 ニューヨーク ユニバーシティ シクロオキシゲナーゼ−2を阻害する方法および腫瘍壊死因子アルファ
AU2203199A (en) 1997-12-30 1999-07-19 Bioabsorbable Concepts, Inc. Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system
US7189703B2 (en) 1998-01-09 2007-03-13 Intracell, Llc Treatment and diagnosis of alzheimer's disease
NZ506058A (en) 1998-01-23 2003-04-29 Tufts College Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
US6277061B1 (en) 1998-03-31 2001-08-21 The Research Foundation Of State University Of New York Method of inhibiting membrane-type matrix metalloproteinase
PT1676579E (pt) * 1998-05-08 2009-03-24 Univ Miami Utilização de tetraciclinas sub-antimicrobianas para o tratamento de rosácea ocular
US6015804A (en) 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5977091A (en) 1998-09-21 1999-11-02 The Research Foundation Of State University Of New York Method of preventing acute lung injury
SE9803710L (sv) * 1998-09-25 2000-03-26 A & Science Invest Ab Användning av vissa substanser för behandling av nervrotsskador
US5998390A (en) 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
ES2272097T3 (es) 1998-11-18 2007-04-16 Collagenex Pharmaceuticals, Inc. Nuevos derivados de 4-desdimetilaminotetraciclina.
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
AU3760400A (en) * 1999-03-19 2000-10-09 Vanderbilt University Methods and reagents for the diagnosis and treatment of multiple sclerosis
EP1171163A1 (en) * 1999-04-27 2002-01-16 Antibody Systems, Inc. Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders
ES2260051T3 (es) 1999-09-14 2006-11-01 Trustees Of Tufts College Metodo para preparar tetraciclinas substituidas con quimicas basadas en metales de transicion.
US6231894B1 (en) 1999-10-21 2001-05-15 Duke University Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase
KR20010069066A (ko) * 2000-01-12 2001-07-23 이종원 저산소 농도하에서 생존이 가능하도록 하는 동물세포의배양방법
AU3105801A (en) 2000-01-24 2001-07-31 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
HUP0300082A2 (en) 2000-03-31 2003-05-28 Paratek Pharmaceuticals 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline derivatives, process for their preparation and use and pharmaceutical compositions containing them
US7235397B1 (en) * 2000-04-14 2007-06-26 Gensys, Inc. Methods and compositions for culturing spirochete and treating spirochetal diseases
US6613756B2 (en) 2000-05-05 2003-09-02 Wisconsin Alumni Research Foundation Use of tetracycline derivatives in treating multiple sclerosis
AU2001259701A1 (en) 2000-05-15 2001-11-26 Paratek Pharmaceuticals, Inc 7-substituted fused ring tetracycline compounds
AU2000257445A1 (en) 2000-06-16 2002-01-02 Trustees Of Tufts College 7-n-substituted phenyl tetracycline compounds
WO2001098236A2 (en) 2000-06-16 2001-12-27 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
AU2000254942A1 (en) 2000-06-16 2002-01-02 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
ATE544745T1 (de) 2000-07-07 2012-02-15 Tufts College 9-substituierte minocyclinverbindungen
CA2415086A1 (en) 2000-07-07 2002-01-17 Trustees Of Tufts College 7,8 and 9-substituted tetracycline compounds
AU2001271642B2 (en) 2000-07-07 2006-01-05 Paratek Pharmaceuticals, Inc. 7-substituted tetracycline compounds
AU2000265203A1 (en) 2000-08-04 2002-02-18 Trustees Of Tufts College 8-substituted tetracycline compounds
WO2002020022A1 (en) 2000-09-06 2002-03-14 Neurotherapeutics, Llc Method of treating neurologic disorders
US20030013692A1 (en) * 2001-01-19 2003-01-16 Gullans Steven R. Methods of treating neurological disorders
JP2005504722A (ja) * 2001-03-14 2005-02-17 パラテック ファーマシューティカルズ インコーポレイテッド 相乗的抗真菌薬剤としての置換テトラサイクリン化合物
CA2457234A1 (en) * 2001-03-14 2002-09-19 Mark L. Nelson Substituted tetracycline compounds as antifungal agents
DE60235083D1 (de) * 2001-04-24 2010-03-04 Paratek Pharm Innc Substituierte tetracyclin-verbindungen zur behandlung von malaria
EP2332548A1 (en) * 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of stroke
CA2469000A1 (en) * 2001-12-07 2003-06-19 Johnson & Johnson Consumer Companies, Inc. Method for reducing acne or improving skin tone
AU2003235759A1 (en) * 2002-01-08 2003-07-24 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
AU2003303666A1 (en) * 2002-01-29 2004-08-13 Protemix Discovery Limited Suppression of cytotoxic protein conformers
EA201000491A1 (ru) * 2002-03-08 2010-08-30 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
DE10228326A1 (de) * 2002-06-25 2004-01-22 Heribert Dr.med. Bohlen Verwendung von Macrolid- und/oder Tetracyclin-Verbindungen und/oder Gyrasehemmer enthaltenden Präparationen zur Prophylaxe und therapeutischen Behandlung von Migräne und Migräne-verwandten Erkrankungen
JP5706185B2 (ja) 2011-02-22 2015-04-22 富士レビオ株式会社 測定装置及び測定方法
US9713502B2 (en) 2014-03-09 2017-07-25 Gyrus Acmi, Inc. Narrow band imaging with surgical loupes

Similar Documents

Publication Publication Date Title
JP2011057693A5 (US20070167479A1-20070719-C00034.png)
JP2019501133A5 (US20070167479A1-20070719-C00034.png)
JP2010090138A5 (US20070167479A1-20070719-C00034.png)
JP2014502641A5 (US20070167479A1-20070719-C00034.png)
JP2014511891A5 (US20070167479A1-20070719-C00034.png)
JP2011517697A5 (US20070167479A1-20070719-C00034.png)
JP2011526924A5 (US20070167479A1-20070719-C00034.png)
JP2008502721A5 (US20070167479A1-20070719-C00034.png)
JP2009536191A5 (US20070167479A1-20070719-C00034.png)
JP2010077141A5 (US20070167479A1-20070719-C00034.png)
JP2012525393A5 (US20070167479A1-20070719-C00034.png)
JP2013508279A5 (US20070167479A1-20070719-C00034.png)
EP2275107A3 (en) Combinations for the treatment of diseases involving cell proliferation
JP2012530779A5 (US20070167479A1-20070719-C00034.png)
JP2013510123A5 (US20070167479A1-20070719-C00034.png)
JP2010501584A5 (US20070167479A1-20070719-C00034.png)
JP2008535902A5 (US20070167479A1-20070719-C00034.png)
JP2009530398A5 (US20070167479A1-20070719-C00034.png)
JP2017526677A5 (US20070167479A1-20070719-C00034.png)
JP2013522230A5 (US20070167479A1-20070719-C00034.png)
JP2013532668A5 (US20070167479A1-20070719-C00034.png)
JP2015508103A5 (US20070167479A1-20070719-C00034.png)
JP2007530703A5 (US20070167479A1-20070719-C00034.png)
JP2014508804A5 (US20070167479A1-20070719-C00034.png)
JP2014518853A5 (US20070167479A1-20070719-C00034.png)